Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, DNA Testing, Elisa Kits, Enzymes, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, NATtrol, Panel, Particles, PCR, Pcr Kits, Peptides, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits, Vector & Virus, Western Blot
hepatitis B virus (HBV) DNA replicates its genome through DNA virus prime reverse transcription polymerase themselves of pre-genomic RNA in the nucleocapsid core protein is assembled by 120 (Cp) dimer. The carboxyl-terminal arginine-rich domain (CTD) Cp play an important role in selective packaging of viral DNA polymerase-pregenomic (pg) RNA into the nucleocapsid complex. Earlier research has suggested that CTD initially phosphorylated at multiple sites to facilitate the packaging of viral RNA and then dephosphorylated with regard to viral DNA synthesis and secretion of DNA containing virions.
However, our recent studies suggest that Cp is hyper-phosphorylated as a free dimer and dephosphorylation associated with pgRNA encapsidation. Here, we provide genetic and biochemical evidence of more extensive supporting Cp dephosphorylation not take place during the assembly pgRNA containing the nucleocapsid, but not empty capsids. In addition, we found that the cellular protein phosphatase 1 (PP1) is necessary for dephosphorylation and packaging pgRNA Cp.
Interestingly, PP1 catalytic subunit α and β are packed into pgRNA containing the nucleocapsid, but not empty capsids, and the treatment of HBV-replicating cells with core protein allosteric modulator (CpAMs) promoted empty capsid assembly and encapsidation repeal of PP1 α and β. Our study thus identified PP1 as the host cellular factors that are co-packaged into the nucleocapsid HBV, and plays an important role in selective packaging of viral DNA-polymerase-catalyzed pgRNA complex via Cp dephosphorylation.
A novel protein tyrosine phosphatase one B inhibitor-geranylated flavonoids from mulberry leaves ameliorates insulin resistance
Mulberry leaf vegetables are common to a variety of beneficial effects, such as hypoglycemic activity. However, the underlying mechanism of the hypoglycemic effect that has not been revealed fully. In this study, two flavonoid derivatives isolated from mulberry leaves, a new geranylated flavonoid compounds (1) and a structural analogue (2). Structures 1 and 2 are described using spectroscopic analysis.
To study the properties of the hypoglycemic potential of this compound, the effect of the regulation of protein tyrosine phosphatase 1B (PTP1B) was investigated. Compared with oleanolic acid, compounds 1 and 2 showed a significant inhibitory activity (IC50 = 4.53 ± 0.31 and 10.53 ± 1.76 M) against PTP1B, a positive control (IC50 = 7.94 ± 0.76 M). molecular docking to predict the binding sites 1 and PTP1B.
In insulin resistance HepG2 cells, first promoted glucose consumption with a dose-dependent manner. Furthermore, western blot and PCR analysis showed that one may regulate the consumption of glucose by PTP1B / IRS / PI3K / AKT pathways. In conclusion, the mulberry leaf flavonoids inhibite geranylated PTP1B and increase the consumption of glucose in insulin-resistant cells. These findings provide an important basis for the use of mulberry leaf flavonoids as a dietary supplement to regulate glucose metabolism.
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC942026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC802026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC802026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC702026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC702026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC882026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC882026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC812026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC812026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC052026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC052026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC042026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC042026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC402026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC402026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCAP2026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCAP2026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCA2026-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), APC conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCP2026-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCR2026-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCH2026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCH2026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCB2026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNCB2026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNUB2026-100 | Biotium | 100uL | EUR 316.8 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Concentration: 0.2mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNUB2026-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), 1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNUB2026-500 | Biotium | 500uL | EUR 615.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), Concentration: 0.2mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC472026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC472026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC612026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC612026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC432026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC432026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC552026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC552026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC682026-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R) Antibody |
|||
| BNC682026-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PTPRC siRNA |
|||
| 20-abx930397 | Abbexa |
|
|
PTPRC siRNA |
|||
| 20-abx930398 | Abbexa |
|
|
PTPRC Antibody |
|||
| 32607-100ul | SAB | 100ul | EUR 302.4 |
PTPRC Antibody |
|||
| ABD6839 | Lifescience Market | 100 ug | EUR 525.6 |
PTPRC Antibody |
|||
| 1-CSB-PA868166 | Cusabio |
|
|
|
Description: A polyclonal antibody against PTPRC. Recognizes PTPRC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:100-1:300 |
|||
PTPRC Antibody |
|||
| CSB-PA019049KA01HU- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against PTPRC. Recognizes PTPRC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
PTPRC Antibody |
|||
| CSB-PA019049KA01HU-100ul | Cusabio | 100ul | EUR 466.8 |
|
Description: A polyclonal antibody against PTPRC. Recognizes PTPRC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
|||
PTPRC Antibody |
|||
| 1-CSB-PA480713 | Cusabio |
|
|
|
Description: A polyclonal antibody against PTPRC. Recognizes PTPRC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
|||
PTPRC Antibody |
|||
| 1-CSB-PA010546 | Cusabio |
|
|
|
Description: A polyclonal antibody against PTPRC. Recognizes PTPRC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/5000 |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC941131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC941131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC941132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC941132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC941147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC941147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC941148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC941148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC801131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC801131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC801132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC801132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC801147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC801147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC801148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC801148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC811131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC811131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC811132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC811132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC811147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC811147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC811148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC811148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC701131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC701131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC701132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC701132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC701147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC701147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC701148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC701148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC881131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC881131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC881132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC881132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC881147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC881147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC881148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC881148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC051131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC051131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC051132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC051132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC051147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC051147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC051148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC051148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC041131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC041131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC041132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC041132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC041147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC041147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC041148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC041148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC401131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC401131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC401132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC401132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC401147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC401147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC401148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC401148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCB1131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCB1131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCB1132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCB1132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCB1147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCB1147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCB1148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCB1148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCAP1131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCAP1131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCAP1132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCAP1132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCAP1147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCAP1147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCAP1148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCAP1148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCA1131-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), APC conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCA1132-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), APC conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCA1147-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), APC conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCA1148-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), APC conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCR1131-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCR1132-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCR1147-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCR1148-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCP1131-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCP1132-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCP1147-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCP1148-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNUM1131-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), 1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNUM1132-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), 1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNUM1147-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), 1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNUM1148-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), 1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCH1131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNCH1131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCH1132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNCH1132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCH1147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNCH1147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCH1148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNCH1148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNUB1131-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Concentration: 0.2mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNUB1131-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), Concentration: 0.2mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNUB1132-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Concentration: 0.2mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNUB1132-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), Concentration: 0.2mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNUB1147-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Concentration: 0.2mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNUB1147-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), Concentration: 0.2mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNUB1148-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Concentration: 0.2mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNUB1148-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), Concentration: 0.2mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC611131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC611131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC611132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC611132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC611147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC611147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC611148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC611148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC551131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC551131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC551132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC551132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC551147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC551147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC551148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC551148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC431131-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1131) Antibody |
|||
| BNC431131-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1131), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC431132-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1132) Antibody |
|||
| BNC431132-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1132), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC431147-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RB(PTPRC/1147) Antibody |
|||
| BNC431147-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RB(PTPRC/1147), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC431148-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD45RA(PTPRC/1148) Antibody |
|||
| BNC431148-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD45RA(PTPRC/1148), CF543 conjugate, Concentration: 0.1mg/mL |
|||
ten different cDNA encoding five different protein phosphatase 1 (ppp1) were cloned from Nilaparvata lugens. NlPPP1α and NlPPP1β highly conserved while NlPPP1-Y, NlPPP1-Y1 and Y2 NlPPP1 low-conserved between insects. NlPPP1α and NlPPP1β exhibited expression everywhere, while NlPPP1-Y, NlPPP1-Y1, and NlPPP1-Y2 are clearly detectable from instar nymphs 4 to adult stage of development in males, mainly detected in the internal reproductive organs and body fat than men -laki. nymphs injection with dsRNA of NlPPP1α or NlPPP1β able to reduce the expression of target genes in the range of 71.5 to 91.0%, pushing the maximum mortality rate of 95.2% or 97.2% on day 10 after the injection and eclosion rate fell 65, 5 to 100.0%.
